Tirz 5 mg
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It acts as an engineered single peptide that synergistically binds both GIP and GLP-1 receptors, leading to significant interest in its dual action on insulin secretion and glucose metabolism.
Product Specifications
| Chemical Formula |
C225H348N48O68 |
| Molecular Weight |
4813.0 g/mol |
| CAS Number |
2023788-19-2 |
| PubChem CID |
163285897 |
| Purity |
>99% (Guaranteed) |
| Physical State |
Lyophilized Powder (Sterile Vial) |
Key Research Applications
- Researching the synergistic effects of dual GIP/GLP-1 receptor activation.
- Exploring metabolic pathways related to glucose clearance and pancreatic insulin release.
- Investigating the influence of GIP and GLP-1 co-agonism on appetite control centers.
- Studying potential applications in cardiovascular health and lipid management.
Reconstitution & Reagent Handling
Reconstitute with sterile bacteriostatic water by injecting the water along the inner wall of the vial.
Storage & Stability
Store lyophilized powder at ≤8°C. Once reconstituted, store at 2°C to 8°C.
RESEARCH USE ONLY: This product is a high-purity laboratory chemical. It is synthesized and supplied strictly for laboratory research, in vitro studies, and experimental use. This product is not approved for human or veterinary use, diagnostic procedures, or therapeutic administration.